RemeGen Statistics

Total Valuation

RemeGen has a market cap or net worth of CNY 66.50 billion. The enterprise value is 66.29 billion.

Market Cap	66.50B
Enterprise Value	66.29B

Important Dates

The next confirmed earnings date is Tuesday, April 28, 2026.

Earnings Date	Apr 28, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	355.70M
Shares Outstanding	n/a
Shares Change (YoY)	+2.14%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	11.87%
Owned by Institutions (%)	29.34%
Float	344.63M

Valuation Ratios

The trailing PE ratio is 51.48 and the forward PE ratio is 18.79.

PE Ratio	51.48
Forward PE	18.79
PS Ratio	19.67
PB Ratio	16.93
P/TBV Ratio	17.60
P/FCF Ratio	1,541.11
P/OCF Ratio	263.30
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 101.93, with an EV/FCF ratio of 1,536.15.

EV / Earnings	51.32
EV / Sales	19.77
EV / EBITDA	101.93
EV / EBIT	195.33
EV / FCF	1,536.15

Financial Position

The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.53.

Current Ratio	1.58
Quick Ratio	1.26
Debt / Equity	0.53
Debt / EBITDA	3.19
Debt / FCF	48.53
Interest Coverage	4.88

Financial Efficiency

Return on equity (ROE) is 45.33% and return on invested capital (ROIC) is 10.26%.

Return on Equity (ROE)	45.33%
Return on Assets (ROA)	3.37%
Return on Invested Capital (ROIC)	10.26%
Return on Capital Employed (ROCE)	7.18%
Weighted Average Cost of Capital (WACC)	6.81%
Revenue Per Employee	1.11M
Profits Per Employee	423,819
Employee Count	3,048
Asset Turnover	0.53
Inventory Turnover	0.66

Taxes

In the past 12 months, RemeGen has paid 1.24 million in taxes.

Income Tax	1.24M
Effective Tax Rate	0.10%

Stock Price Statistics

The stock price has increased by +158.55% in the last 52 weeks. The beta is 0.49, so RemeGen's price volatility has been lower than the market average.

Beta (5Y)	0.49
52-Week Price Change	+158.55%
50-Day Moving Average	122.04
200-Day Moving Average	96.23
Relative Strength Index (RSI)	50.14
Average Volume (20 Days)	10,388,640

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, RemeGen had revenue of CNY 3.38 billion and earned 1.29 billion in profits. Earnings per share was 2.33.

Revenue	3.38B
Gross Profit	2.94B
Operating Income	342.15M
Pretax Income	1.29B
Net Income	1.29B
EBITDA	598.24M
EBIT	342.15M
Earnings Per Share (EPS)	2.33

Balance Sheet

The company has 2.75 billion in cash and 2.09 billion in debt, giving a net cash position of 650.96 million.

Cash & Cash Equivalents	2.75B
Total Debt	2.09B
Net Cash	650.96M
Net Cash Per Share	n/a
Equity (Book Value)	3.93B
Book Value Per Share	6.95
Working Capital	1.51B

Cash Flow

In the last 12 months, operating cash flow was 252.59 million and capital expenditures -209.43 million, giving a free cash flow of 43.15 million.

Operating Cash Flow	252.59M
Capital Expenditures	-209.43M
Depreciation & Amortization	256.09M
Net Borrowing	-408.90M
Free Cash Flow	43.15M
FCF Per Share	n/a

Margins

Gross margin is 86.86%, with operating and profit margins of 10.12% and 38.20%.

Gross Margin	86.86%
Operating Margin	10.12%
Pretax Margin	38.24%
Profit Margin	38.20%
EBITDA Margin	17.69%
EBIT Margin	10.12%
FCF Margin	1.28%

Dividends & Yields

RemeGen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	4.72%
Buyback Yield	-2.14%
Shareholder Yield	-2.14%
Earnings Yield	1.94%
FCF Yield	0.06%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7